Skip to content

AstraZeneca COVID-19 vaccine study put on hold after adverse reaction

September 8, 2020

via STAT News

“Standard review process triggered a pause to vaccination to allow review of safety data,” says an AstraZeneca (NYSE:AZN) spokesperson after a Phase 3 study of its COVID-19 vaccine (developed with University of Oxford) has been put on hold across the U.S. after a suspected serious adverse reaction on a U.K. participant.

https://seekingalpha.com/news/3612325-astrazeneca-covidminus-19-vaccine-study-put-on-hold-after-adverse-reaction

From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: